Utama › Limfoma Bukan Hodgkin › Ohio › Cleveland
Kajian klinikal Limfoma Bukan Hodgkin di Cleveland, OH
13 kajian untuk Limfoma Bukan Hodgkin sedang mencari peserta di lokasi dalam dan sekitar Cleveland (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Mengambil pesertaFasa 1/2
- University Hospitals Seidman Cancer Center, Cleveland
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Mengambil pesertaFasa 1
- Cleveland Clinic, Cleveland
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Mengambil pesertaFasa 1
- Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, Cleveland
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Mengambil pesertaFasa 1
- Clinical Trial Site, Cleveland
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Mengambil pesertaFasa 1/2
- Cleveland Clinic, Cleveland
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Mengambil pesertaFasa 3
- Cleveland Clinical Taussig Cancer Center, Cleveland
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Mengambil pesertaKajian pemerhatian
- University Hospitals Case Medical Center, Cleveland
- Cleveland Clinic, Cleveland
Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab
Mengambil pesertaFasa 1
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Mengambil pesertaFasa 1/2
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi jauh
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Mengambil pesertaFasa 1
- University Hospitals Cleveland Medical Center, Cleveland
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Mengambil pesertaFasa 1/2
- University Hospitals Cleveland, Cleveland
Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma
Mengambil pesertaFasa 1
- University Hospitals Seidman Cancer Center, Cleveland
- Taussig Cancer Institute | Cleveland Clinic, Cleveland
Kajian Limfoma Bukan Hodgkin di bandar lain
- New York City, NY31 kajian
- Houston, TX31 kajian
- Boston, MA26 kajian
- Nashville, TN21 kajian
- Philadelphia, PA20 kajian
- Baldwin Park, CA19 kajian
- Washington, DC18 kajian
- Chicago, IL18 kajian
- Atlanta, GA18 kajian
- Milwaukee, WI18 kajian
- Columbus, OH18 kajian
- Dallas, TX17 kajian
Kajian lain di Cleveland
- Kanser Paru-paru Bukan Sel Kecil43 kajian
- Kanser (semua jenis)36 kajian
- Kanser Payudara35 kajian
- Kanser Prostat34 kajian
- Kegagalan Jantung33 kajian
- Kanser Ovari30 kajian
- Kanser Metastatik30 kajian
- Kanser Paru-paru26 kajian
- Kanser Kolorektal24 kajian
- Penyakit Kardiovaskular22 kajian
- Kanser Endometrium20 kajian
- Leukemia Mieloid Akut20 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.